In recent years, a large number of studies have focused on the activation of HSCs in liver fibrosis by TGF-β/Smad, MAPK, PI3K/AKT, Wnt, NF-κB, and AMPK signaling pathways. Here, NFKB1 is linked to Hepatic fibrosis.